NS · Healthcare

Sat Kartar Life Ltd (SATKARTAR)

Pharmaceuticals & Biotechnology

Sat Kartar Life Ltd (SATKARTAR) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $2.21B, P/E ratio is 15.05, dividend yield is 0.50%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SATKARTAR

Market cap

$2.21B

P/E ratio

15.05

Dividend yield

0.50%

Sat Kartar Life Ltd (SATKARTAR) — FAQ

What is Sat Kartar Life Ltd's market cap?

Sat Kartar Life Ltd (SATKARTAR) has a reported market cap of $2.21B (data as of 2026-07-10).

What is SATKARTAR's P/E ratio?

The price-to-earnings (P/E) ratio for Sat Kartar Life Ltd (SATKARTAR) is 15.05 (data as of 2026-07-10).

Does Sat Kartar Life Ltd pay a dividend?

Sat Kartar Life Ltd (SATKARTAR) shows a reported dividend yield of 0.50%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Sat Kartar Life Ltd in?

Sat Kartar Life Ltd (SATKARTAR) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is SATKARTAR listed on?

SATKARTAR is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)